Terms: = Gastric cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Diagnosis
5 results:
1. The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer.
Li XF; Zhang XJ; Hao FR; Dong XT; Xu GD; Zhang YX
J Int Med Res; 2024 Mar; 52(3):3000605241234558. PubMed ID: 38518198
[TBL] [Abstract] [Full Text] [Related]
2. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
Chen DH; Yu JW; Jiang BJ
World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
[TBL] [Abstract] [Full Text] [Related]
3. VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Thomaidis T; Maderer A; Al-Batran SE; Kany J; Pauligk C; Steinmetz K; Schad A; Hofheinz R; Schmalenberg H; Homann N; Galle PR; Moehler M
BMC Cancer; 2014 Jul; 14():476. PubMed ID: 24981311
[TBL] [Abstract] [Full Text] [Related]
4. More attention should be paid on the interpretation of gene expression data.
Verna E
World J Gastroenterol; 2012 Jun; 18(24):3181-2. PubMed ID: 22791956
[TBL] [Abstract] [Full Text] [Related]
5. Multiple gastric involvement by myeloid antigen CD13-positive non-secretory plasma cell leukaemia.
Ohsaka A; Sato N; Imai Y; Hirai S; Oka Y; Kikuchi M; Takahashi A
Br J Haematol; 1996 Jan; 92(1):134-6. PubMed ID: 8562384
[TBL] [Abstract] [Full Text] [Related]
